BIO Asia–Taiwan 2026_Tickets_Dates_Booths_Exhibitors - ExpoFinder

BIO Asia–Taiwan 2026

Dedicated to biotechnology, life sciences, and commercialization, ideal for reaching Taiwan and Asia-Pacific research, pharma, and investment partners.

EndedInternational Conference and ExhibitionBIO PartneringPrecision Medicine and Smart Medical

Exhibition Data

3w+sqm

Area

300exhibitors

Exhibitors

2w+visitors

Visitors

Onsite Gallery

Exhibited Products

Biopharmaceutical and Medical

BiopharmaceuticalsMedical

Medical Device

Medical ElectronicsMedical ImagingMedical Materials

Precision Medicine and Genetic Test

Gene SequencingGene EditingLiquid Biopsy

Precision Health and Smart Medical

AIIoTWearable Devices

Biotechnology Service

Medical ServiceClinical Trial ServiceCRO/CMO

Country Pavilion

Government, Academia and Research Institutes

CRO

Exhibitor List

July 2026

360BIOLABS PTY LTD

M704

AcadeMab Biomedical Inc.

M534

Acer Incorporated

M534

ACM Global Laboratories

M1108

- No product images -

ACRO Biomedical Co., Ltd.

M925

ADVANCED CTS CORP.(ACTS)

M607

- No product images -

10 total

2 pages

Forum Activities

73 events

14:3514:50

Any Target, Every Time: How Proximity-Based Therapeutics Have Redefined Druggability

Ryan Potts, Vice President, Research/ Head, DATA (Discovery Science, Advanced Technologies, and AI)/ Chair, R&D Postdoc Program, Amgen

2026-07-15

TaiNEX, Taipei

14:5015:05

DRIVING THE FUTURE OF MEDICINE WITH NEW MODALITIES

2026-07-15

TaiNEX, Taipei

14:5015:05

Radioligand Therapy: The Next Frontier in Precision Oncology

Bimba HV, Cluster Head- Clinical Research Medical Advisor, Novartis

2026-07-15

TaiNEX, Taipei

15:0515:20

From Ex vivo to In vivo precision Genetic Medicine

Tony Ho, Senior Science Partner, Pivotal Bioventure and Chief Executive Officer of Land Therapeutics

2026-07-15

TaiNEX, Taipei

16:2516:40

Smart Trials, Faster Starts: AI-Driven Clinical Trial Start-Up and the Role of Taiwan’s TACTC Network

Mai-Szu Wu, President, Taipei Medical University

2026-07-15

TaiNEX, Taipei

16:4016:55

From Preclinical Signals to Clinical Wins with AI in Respiratory Disease: Future Directions

Kazuhiro Ito, Professor (Principal Research Fellow) of Respiratory Molecular Pharmacology in Genomic and Environmental Medicine Section in National Heart and Lung Institute (NHLI) in the Faculty of Medicine of Imperial College London

2026-07-15

TaiNEX, Taipei